200 participants
Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-03
- Start Date:
- 2023-03-24
- Completion:
- 2027-07-01
Conditions
- Metastatic Papillary Renal Cell Carcinoma
- Stage IV Renal Cell Cancer AJCC v8
Interventions
- BIOLOGICAL
- PROCEDURE
- DRUG
No Results Yet